Cyclo Therapeutics Inc Stock Ownership - Who owns Cyclo Therapeutics?

Insider buying vs selling

Have Cyclo Therapeutics Inc insiders been buying or selling?
N. Scott FineChief Executive Officer2023-10-20299,402$0.71
Francis Patrick OstronicDirector2023-10-2059,881$0.71
Rafael Holdings Inc10% Owner2023-10-202,514,970$0.71
Markus SiegerDirector2023-10-2059,881$0.71
Jeffrey TateChief Operating Officer2023-10-2029,941$0.71
Rafael Holdings Inc10% Owner2023-08-014,000,000$1.25

1 of 1

CYTH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTH insiders and whales buy or sell their stock.

CYTH Shareholders

What type of owners hold Cyclo Therapeutics Inc stock?
Armistice Capital LLC110.40%31,591,538$39.17MInsider
Novit LP75.19%21,517,582$26.68MInsider
Rafael Holdings Inc31.56%9,029,940$11.20MInsider
George L. Fails5.89%1,685,221$2.09MInsider
Joseph J. Farnan Jr.4.68%1,340,000$1.66MInsider
Epiq Capital Group LLC2.98%853,815$1.06MInstitution
N. Scott Fine2.60%743,804$922.32kInsider
Founders Fund V Management LLC1.68%480,708$596.08kInstitution
Vanguard Group Inc1.39%396,658$491.86kInstitution
Francis Patrick Ostronic1.22%348,771$432.48kInsider

1 of 3

CYTH vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTH3.11%96.89%Net Buying
CPIX15.24%58.39%Net BuyingNet Selling
TXMD3.69%96.31%Net Buying

Cyclo Therapeutics Stock Ownership FAQ

Who owns Cyclo Therapeutics?

Cyclo Therapeutics (NASDAQ: CYTH) is owned by 7.56% institutional shareholders, 235.55% Cyclo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Cyclo Therapeutics shareholder, owning 31.59M shares representing 110.40% of the company. Armistice Capital LLC's Cyclo Therapeutics shares are currently valued at $36.96M.

If you're new to stock investing, here's how to buy Cyclo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.